![John Stark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Stark
Directeur Général chez Q-SI Operations, Inc.
Profil
John Stark currently works at Q-SI Operations, Inc., as Chief Executive Officer and Resolve BioSciences GmbH, as Chief Executive Officer from 2023.
Mr. Stark also formerly worked at Celsee LLC, as Chief Executive Officer & Director from 2018 to 2020, Quantum-Si, Inc., as Chief Executive Officer & Director from 2020 to 2022, Pacific Biosciences of California, Inc., as Senior Director-Sales from 2009 to 2011, Affymetrix, Inc., as District Manager-East Region Industrial Sales from 2001 to 2007, Standard BioTools, Inc., as Senior VP-Global Commercial Operations from 2015 to 2017, and Life Technologies Corp., as Vice President-Clinical & Applied Markets from 2011 to 2015.
Mr. Stark received his graduate degree from Arizona State University.
Postes actifs de John Stark
Sociétés | Poste | Début |
---|---|---|
Q-SI Operations, Inc.
![]() Q-SI Operations, Inc. BiotechnologyHealth Technology Q-SI Operations, Inc. develops protein sequencing technologies to decode molecules life. The company was founded by Jonathan Rothberg and is headquartered in Guilford, CT. | Directeur Général | - |
Resolve BioSciences GmbH
![]() Resolve BioSciences GmbH BiotechnologyHealth Technology Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023. | Directeur Général | 15/03/2023 |
Anciens postes connus de John Stark
Sociétés | Poste | Fin |
---|---|---|
QUANTUM-SI INCORPORATED | Directeur Général | 08/02/2022 |
Celsee LLC
![]() Celsee LLC Medical SpecialtiesHealth Technology Celsee Diagnostics, Inc. develops, manufactures, and markets integrated comprehensive single-cell analysis solutions. It provides identification, analysis, and retrieves single cells from blood and tissue. The company was founded by Priyadarshini Gogoi, Saedeh Sepehri, and Christopher Siemer in 2011 and is headquartered in Ann Arbor, MI. | Directeur Général | 01/04/2020 |
STANDARD BIOTOOLS INC. | Corporate Officer/Principal | 01/10/2017 |
Life Technologies Corp.
![]() Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Directeur Technique/Scientifique/R&D | 01/10/2015 |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Sales & Marketing | 01/09/2011 |
Formation de John Stark
Arizona State University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
QUANTUM-SI INCORPORATED | Technology Services |
STANDARD BIOTOOLS INC. | Health Technology |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Celsee LLC
![]() Celsee LLC Medical SpecialtiesHealth Technology Celsee Diagnostics, Inc. develops, manufactures, and markets integrated comprehensive single-cell analysis solutions. It provides identification, analysis, and retrieves single cells from blood and tissue. The company was founded by Priyadarshini Gogoi, Saedeh Sepehri, and Christopher Siemer in 2011 and is headquartered in Ann Arbor, MI. | Health Technology |
Q-SI Operations, Inc.
![]() Q-SI Operations, Inc. BiotechnologyHealth Technology Q-SI Operations, Inc. develops protein sequencing technologies to decode molecules life. The company was founded by Jonathan Rothberg and is headquartered in Guilford, CT. | Health Technology |
Life Technologies Corp.
![]() Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Commercial Services |
Affymetrix, Inc.
![]() Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Resolve BioSciences GmbH
![]() Resolve BioSciences GmbH BiotechnologyHealth Technology Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023. | Health Technology |